查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
南美洲和中美洲主动脉瓣置换设备市场预测至 2030 年 - 区域分析 - 按产品、手术和最终用户
市场调查报告书
商品编码
1463640

南美洲和中美洲主动脉瓣置换设备市场预测至 2030 年 - 区域分析 - 按产品、手术和最终用户

South & Central America Aortic Valve Replacement Devices Market Forecast to 2030 - Regional Analysis - by Product, Surgery, and End User
出版日期: | 出版商: The Insight Partners | 英文 83 Pages | 订单完成后即时交付

价格

南美洲和中美洲主动脉瓣置换装置市场预计将从2022年的3.6563亿美元CAGR到2030年的8.7641亿美元。

主动脉瓣置换装置的进步推动了南美洲和中美洲主动脉瓣置换装置市场

微创手术技术（MIS）的发展，例如经导管主动脉瓣置换术（TAVR），使主动脉瓣狭窄（AS）的治疗现代化。经导管主动脉瓣置换术比传统的心臟直视手术侵入性更小，使得不适合手术的高风险患者能够接受治疗。此外，材料和设计的发展导致了更坚固和生物相容性主动脉瓣置换术的开发，这改善了患者的治疗结果并降低了併发症的风险。

以下提到了主动脉瓣置换装置领域的一些技术进步：

2023 年 1 月，雅培 (Abbott) 的 Navitor 经导管主动脉瓣植入 (TAVI) 系统获得 FDA 批准，用于治疗心臟直视手术高风险的严重主动脉瓣狭窄患者。 Navitor 是该公司广泛的经导管结构性心臟产品组合的最新成员，为医生和患者提供一系列严重心臟病的微创治疗选择。

2021 年 9 月，雅培的 Epic Plus 和 Epic Plus Supra 支架组织瓣膜获得 FDA 批准，以改善主动脉瓣或二尖瓣疾病患者的治疗选择。透过这款新设备，雅培扩展了其 Epic 手术瓣膜平台。

因此，技术进步正在主动脉瓣置换装置市场创造利润丰厚的机会。

南美洲和中美洲主动脉瓣置换设备市场概述

南美洲和中美洲主动脉瓣置换装置市场分为巴西、阿根廷以及南美洲和中美洲其他地区。由于主动脉瓣狭窄盛行率激增，各政府组织为提高人们对瓣膜置换手术的认识而采取的倡议，预计该地区的市场将会成长。

南美洲及中美洲主动脉瓣置换设备市场收入及 2030 年预测（百万美元）

南美洲和中美洲主动脉瓣置换设备市场细分

南美洲和中美洲主动脉瓣置换装置市场分为产品、手术、最终用户和国家。

根据产品，南美洲和中美洲主动脉瓣置换装置市场分为无缝线瓣膜和机械瓣膜。到 2022 年，无缝线瓣膜将在南美洲和中美洲主动脉瓣置换设备市场中占据更大份额。

根据手术，南美洲和中美洲主动脉瓣置换装置市场分为微创手术和开放性手术。到 2022 年，微创手术细分市场将在南美洲和中美洲主动脉瓣置换设备市场中占据更大份额。

根据最终用户，南美洲和中美洲主动脉瓣置换设备市场分为医院和诊所、门诊手术中心等。到 2022 年，医院和诊所细分市场将占据南美洲和中美洲主动脉瓣置换设备最大的市场份额。

根据国家/地区，南美洲和中美洲主动脉瓣置换装置市场分为巴西、阿根廷以及南美洲和中美洲其他地区。 2022 年，巴西在南美洲和中美洲主动脉瓣置换设备市场份额中占据主导地位。

雅培实验室、美敦力公司、波士顿科学公司、LivaNova Plc、Edwards Lifesciences Corp、Braile Biomedica Industry, Commerce and Representations Ltd、Artivion Inc、启明医疗科技杭州有限公司和 Labcor Laboratorios Ltda。 ，是主动脉瓣置换设备市场上的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：南美洲和中美洲主动脉瓣置换设备市场模式

  • 概述
  • PEST分析
    • 南美洲和中美洲 PEST 分析

第 5 章：南美洲和中美洲主动脉瓣置换设备市场 - 主要产业动态

  • 主要市场驱动因素：
    • 主动脉瓣置换手术数量不断增加
    • 对微创技术的需求不断增加
  • 市场限制
    • 产品召回
    • 关于结构心臟装置的严格规定
  • 市场机会
    • 主动脉瓣置换装置的进步
  • 未来的趋势
    • 临床研究数量不断增加
  • 影响分析：

第 6 章： 主动脉瓣置换设备市场 - 南美洲和中美洲市场分析

  • 南美洲和中美洲主动脉瓣置换设备市场收入，2022 - 2030

第 7 章：南美洲和中美洲主动脉瓣置换设备市场 - 收入和 2030 年预测 - 按产品

  • 概述
  • 南美洲和中美洲主动脉瓣置换设备市场收入份额（按产品）2022 年和 2030 年（%）
  • 机械阀
  • 无缝线瓣膜

第 8 章：南美洲和中美洲主动脉瓣置换设备市场 - 收入和 2030 年预测 - 通过手术。

  • 概述
  • 2022 年和 2030 年南美洲和中美洲主动脉瓣置换设备市场收入份额（按手术划分）
  • 开放性手术
  • 微创手术

第 9 章：南美洲和中美洲主动脉瓣置换设备市场 - 收入和 2030 年预测 - 按最终用户。

  • 概述
  • 2022 年和 2030 年南美洲和中美洲主动脉瓣置换设备市场收入份额（按最终用户划分）（%）
  • 医院和诊所
  • 门诊手术中心
  • 其他的

第 10 章：南美洲和中美洲主动脉瓣置换设备市场 - 国家分析

  • 巴西
  • 阿根廷
  • 南美洲和中美洲其他地区

第 11 章：全球主动脉瓣置换设备市场产业格局

  • 概述
  • 南美洲和中美洲主动脉瓣置换设备市场的成长策略
  • 有机成长策略
    • 概述
  • 无机成长策略
    • 概述

第 12 章：主要公司简介

  • Abbott Laboratories
  • Medtronic Plc
  • Boston Scientific Corp
  • LivaNova Plc
  • Edwards Lifesciences Corp
  • Braile Biomedica Industry, Commerce and Representations Ltd
  • Artivion Inc
  • Venus MedTech HangZhou Inc
  • Labcor Laboratorios Ltda.

第 13 章：附录

Product Code: BMIRE00029441

The South & Central America aortic valve replacement devices market is expected to grow from US$ 365.63 million in 2022 to US$ 876.41 million by 2030. It is estimated to grow at a CAGR of 11.5% from 2022 to 2030.

Advancements in Aortic Valve Replacement Devices Fuels South & Central America Aortic Valve Replacement Devices Market

The development of minimally invasive surgical techniques (MIS), such as transcatheter aortic valve replacement (TAVR), has modernized the treatment of aortic stenosis (AS). Transcatheter aortic valve replacement is less invasive than traditional open-heart surgery, making it possible for high-risk patients who may not have been eligible for surgery to receive treatment. Moreover, developments in materials and design have led to the development of stronger and biocompatible aortic valve replacements, which have improved patient outcomes and reduced the risk of complications.

A few technological advancements by the players in the aortic valve replacement devices are mentioned below:

In January 2023, Abbott received FDA approval for the Navitor transcatheter aortic valve implantation (TAVI) system to treat people with severe aortic stenosis at high risk of open-heart surgery. Navitor is the latest addition to the company's extensive transcatheter structural heart portfolio, which offers physicians and patients less invasive treatment options for a range of serious heart diseases.

In September 2021, Abbott received FDA approval for its Epic Plus and Epic Plus Supra Stented Tissue Valves to improve therapy options for people with aortic or mitral valve disease. With this new device, Abbott expanded its Epic surgical valve platform.

Therefore, technological advancements are creating lucrative opportunities in the aortic valve replacement devices market.

South & Central America Aortic Valve Replacement Devices Market Overview

The South & Central America aortic valve replacement devices market is segmented into Brazil, Argentina, and the Rest of South & Central America. The market in the region is expected to grow due to the surge in prevalence of aortic stenosis, initiatives undertaken by various government organizations to create awareness about valve replacement surgeries.

South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Million)

South & Central America Aortic Valve Replacement Devices Market Segmentation

The South & Central America aortic valve replacement devices market is segmented into product, surgery, end user, and country.

Based on product, the South & Central America aortic valve replacement devices market is segmented into sutureless valve and mechanical valve. The sutureless valve held a larger South & Central America aortic valve replacement devices market share in 2022.

Based on surgery, the South & Central America aortic valve replacement devices market is segmented into minimally invasive surgery and open surgery. The minimally invasive surgery segment held a larger South & Central America aortic valve replacement devices market share in 2022.

Based on end user, the South & Central America aortic valve replacement devices market is segmented into hospitals & clinics, ambulatory surgical centers, and others. The hospitals & clinics segment held the largest South & Central America aortic valve replacement devices market share in 2022.

Based on country, the South & Central America aortic valve replacement devices market has been categorized into Brazil, Argentina, and the Rest of South & Central America. Brazil dominated the South & Central America aortic valve replacement devices market share in 2022.

Abbott Laboratories, Medtronic Plc, Boston Scientific Corp, LivaNova Plc, Edwards Lifesciences Corp, Braile Biomedica Industry, Commerce and Representations Ltd, Artivion Inc, Venus MedTech HangZhou Inc, and Labcor Laboratorios Ltda. , are some of the leading companies operating in the aortic valve replacement devices market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. South & Central America Aortic Valve Replacement Devices Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 South & Central America PEST Analysis

5. South & Central America Aortic Valve Replacement Devices Market - Key Industry Dynamics

  • 5.1 Key Market Drivers:
    • 5.1.1 Rising Number of Aortic Valve Replacement Surgeries
    • 5.1.2 Increasing Demand for Minimally Invasive Techniques
  • 5.2 Market Restraints
    • 5.2.1 Product Recalls
    • 5.2.2 Stringent Regulations Regarding Structure Heart Devices
  • 5.3 Market Opportunities
    • 5.3.1 Advancements in Aortic Valve Replacement Devices
  • 5.4 Future Trends
    • 5.4.1 Increasing Number of Clinical Studies
  • 5.5 Impact Analysis:

6. Aortic Valve Replacement Devices Market - South & Central America Market Analysis

  • 6.1 South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030

7. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 Mechanical Valve
    • 7.3.1 Overview
    • 7.3.2 Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Sutureless Valve
    • 7.4.1 Overview
    • 7.4.2 Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

8. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by Surgery.

  • 8.1 Overview
  • 8.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery, 2022 & 2030 (%)
  • 8.3 Open Surgery
    • 8.3.1 Overview
    • 8.3.2 Open Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Minimally Invasive Surgery
    • 8.4.1 Overview
    • 8.4.2 Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

9. South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 - by End User.

  • 9.1 Overview
  • 9.2 South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User, 2022 & 2030 (%)
  • 9.3 Hospitals & Clinics
    • 9.3.1 Overview
    • 9.3.2 Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.4 Ambulatory Surgery Centers
    • 9.4.1 Overview
    • 9.4.2 Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.5 Others
    • 9.5.1 Overview
    • 9.5.2 Others: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)

10. South & Central America Aortic Valve Replacement Devices Market - Country Analysis

  • 10.1 South & Central America Aortic Valve Replacement Devices Market, Revenue and Forecast to 2030
    • 10.1.1 Overview
    • 10.1.2 South & Central America Aortic Valve Replacement Devices Market by Country
      • 10.1.2.1 Brazil
        • 10.1.2.1.1 Overview
        • 10.1.2.1.2 Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.1.3 Brazil Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.1.4 Brazil Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.1.5 Brazil Aortic Valve Replacement Devices Market, by End-User
      • 10.1.2.2 Argentina
        • 10.1.2.2.1 Overview
        • 10.1.2.2.2 Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.2.3 Argentina Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.2.4 Argentina Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.2.5 Argentina Aortic Valve Replacement Devices Market, by End-User
      • 10.1.2.3 Rest of South & Central America
        • 10.1.2.3.1 Overview
        • 10.1.2.3.2 Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
        • 10.1.2.3.3 Rest of South & Central America Aortic Valve Replacement Devices Market, by Product
        • 10.1.2.3.4 Rest of South & Central America Aortic Valve Replacement Devices Market, by Surgery
        • 10.1.2.3.5 Rest of South & Central America Aortic Valve Replacement Devices Market, by End-User

11. Global Aortic Valve Replacement Devices Market Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in South & Central America Aortic Valve Replacement Devices Market
  • 11.3 Organic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Inorganic Growth Strategies
    • 11.4.1 Overview

12. Key Company Profiles

  • 12.1 Abbott Laboratories
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Medtronic Plc
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 Boston Scientific Corp
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 LivaNova Plc
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Edwards Lifesciences Corp
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 Braile Biomedica Industry, Commerce and Representations Ltd
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Artivion Inc
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Venus MedTech HangZhou Inc
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Labcor Laboratorios Ltda.
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. South & Central America Aortic Valve Replacement Devices Market Segmentation
  • Table 2. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 4. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 5. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 6. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 7. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 8. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 9. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - Surgery
  • Table 10. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn) - End-User
  • Table 11. Recent Organic Growth Strategies in Aortic Valve Replacement Devices Market
  • Table 12. Recent Inorganic Growth Strategies in the Aortic Valve Replacement Devices Market
  • Table 13. Glossary of Terms, Aortic Valve Replacement Devices Market

List Of Figures

  • Figure 1. South & Central America Aortic Valve Replacement Devices Market Segmentation, By Country
  • Figure 2. South & Central America - PEST Analysis
  • Figure 3. South & Central America Aortic Valve Replacement Devices Market - Key Industry Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. South & Central America Aortic Valve Replacement Devices Market Revenue (US$ Mn), 2022 - 2030
  • Figure 6. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 7. Mechanical Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Sutureless Valve: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by Surgery 2022 & 2030 (%)
  • Figure 10. Open Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Minimally Invasive Surgery: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. South & Central America Aortic Valve Replacement Devices Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 13. Hospitals & Clinics: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Ambulatory Surgery Centers: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Others: South & Central America Aortic Valve Replacement Devices Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Aortic Valve Replacement Devices Market, By country, 2022 ($Mn)
  • Figure 17. South & Central America Aortic Valve Replacement Devices Market, By Key Countries, 2022 and 2030 (%)
  • Figure 18. Brazil Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 19. Argentina Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 20. Rest of South & Central America Aortic Valve Replacement Devices Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 21. Growth Strategies in South & Central America Aortic Valve Replacement Devices Market